The hysteroscope market size is projected to grow from USD 238.3 Million in 2021 to surpass USD 346.4 Million by 2030, registering a CAGR of 4.70% from 2021 to 2030, according to a new report by Reports and Data.
The increasing use of hysteroscopes for fertility examinations, abnormal uterine bleeding, and transcervical sterilizations are some of the chief factors augmenting the market growth.
Hysteroscopy is a minimally invasive diagnostic method used to detect intrauterine and endocervical conditions. Hysteroscopic myomectomy, polypectomy, and endometrial ablation are commonly performed procedures that use a hysteroscope device. In Canada, nearly 16% of couples experience infertility, and assisted human reproduction differs in each province. For instance, in British Columbia, Medical Services Plan, a publicly funded care system, ensures easy access to healthcare services.
Market growth can be attributed to the increased occurrence of female diseases such as abnormal uterine bleeding, transcervical sterilization, and fertility disorders. Hysteroscopy is used to evaluate uterine abnormalities and is increasingly being utilized for fertility assistance. A rise in the number of couples opting for Assisted Reproduction Technology procedures is expected to boost the hysteroscope market.
Request a Sample@ https://www.qyresearchmedical.com/sample/119165
Hysteroscopy helps in a speedy recovery, minimized hospitalizations, and minimal blood loss. The procedure is preferred due to its low post-operational discomfort, allowing patients to resume their routine activities in relatively less number of days than traditional invasive procedures. Moreover, hysteroscopy enables gynecologists to examine endometrial health and plan an appropriate surgical solution.
New developments and advancements in technology have enhanced instrumentation and equipment used to perform a hysteroscopy. Optical light channels in hysteroscope were traditionally available with an outer diameter of 3 to 4 mm. However, current rigid endoscopes have a diameter of 1.9 mm with many separate lenses in the optical fiber system. The resultant image is enhanced and obtained from individual fibers separately.
On the basis of type, the market is segmented into rigid and flexible hysteroscopes. Rigid hysteroscope held the largest share in 2019 and is projected to dominate the hysteroscope product segment over the forecast period. Rigid hysteroscopes are extensively used in hospitals and clinics due to the availability of a wide range of diameters, allowing in-office and operating room procedures. Flexible hysteroscopes provide full visualization but are difficult to use in case of procedures related to endometrial lesions.
Based on application, the market is segmented into myomectomy, polypectomy, endometrial ablation, and others. The myomectomy segment dominated the market in terms of revenue share in 2022. Hysteroscopy is performed to treat various clinical conditions, especially prolonged infertility. This procedure is helpful in diagnosing the cause of multiple miscarriages. It also assists in evaluating pelvic pain in women. Furthermore, in some cases, operative hysteroscopy is used to remove adhesions, which are scar tissues that form in the uterus. Operative hysteroscopy can be performed during a diagnostic hysteroscopy, avoiding the need for a second surgery.
Based on end-use, the market is divided into hospitals, ambulatory surgical centers, gynecology clinics, and others. Hospitals dominated the market in 2022, and the gynecology clinics segment is likely to grow at the fastest rate during the forecast period. This can be attributed to a rapid increase in the number of hospital facilities and gynecology diagnosis & treatment units.
North America held the largest share in 2022. This can be attributed to the presence of key market players, favorable government regulations & reimbursement policies, approval & commercialization of products, and a rise in awareness about women’s health. Moreover, increasing demand for minimally-invasive procedures and growing R&D for gynecological systems are some factors responsible for growth in the U.S. In August 2022, the U.S. FDA approved Luminelle DTx Hysteroscopy System by UVision360 for hysteroscopy and cystoscopy. The system allows physicians to perform in-office hysteroscopic procedures such as biopsy and detection of abnormal tissue growth.
Asia Pacific is projected to exhibit the fastest growth during the forecast period. This is due to increasing awareness about women’s health, supportive government initiatives for reimbursement, and rising incidence of infertility & other associated disorders.
Some of the prominent players in the market include Stryker, Olympus Corporation, Ethicon, Inc., Hologic, Inc., Richard Wolf GmbH, Xion, Welch Allyn, Medtronic, Boston Scientific Corporation, and Coopersurgical Inc., among others.
Segments covered in the report:
This report forecasts revenue growth at a global, regional, and country level, and provides an analysis of the industry trends in each sub-segment from 2021 to 2030. For the purpose of this report, Reports and Data has segmented into the Global Hysteroscope Market on the basis of type, application, end-user, and region:
Type Outlook (Revenue, USD Billion; 2022-2030)
- Flexible Hysteroscope
- Rigid Hysteroscope
Application Outlook (Revenue, USD Billion; 2022-2030)
- Myomectomy
- Endometrial Ablation
- Polypectomy
- Others
End-User Outlook (Revenue, USD Billion; 2022-2030)
- Gynecology Clinics
- Ambulatory Surgical Centers
- Hospitals
- Others
Regional Outlook (Revenue, USD Billion; 2022-2030)
- North America
- U.S.
- Europe
- U.K.
- France
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119165/1500
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/